Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 815-827 , December 2009

Selenium and thyroid

  • Josef Köhrle, PhD (Director)

      Affiliations

    • Institut für Experimentelle Endokrinologie, Charité Universitätsmedizin Berlin, CVK, D-13353 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 30 450 524022; Fax: +49 30 450 524922.
    • ,
  • Roland Gärtner, MD (Head of the Department of Endocrinology and Intensive Care Unit)

      Affiliations

    • Department of Endocrinology, Medizinische Klinik Innenstadt, University of Munich, D-80336 Munich, Germany
    • Tel.: +49 89 5160 2332; Fax: +49 89 5160 4430.

References 

  1. Schomburg L, Köhrle J. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Molecular Nutrition & Food Research. 2008;52(11):1235–1246
  2. Schmutzler C, Mentrup B, Schomburg L, et al. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biological Chemistry. 2007;388(10):1053–1059
  3. Köhrle J, Jakob F, Contempre B, et al. Selenium, the thyroid, and the endocrine system. Endocrine Reviews. 2005;26(7):944–984
  4. Dickson RC, Tomlinson RH. Selenium in blood and human tissues. Clinica Chimica Acta. 1967;16:311–321
  5. Aaseth J, Frey H, Glattre E, et al. Selenium concentrations in the human thyroid gland. Biological Trace Element Research. 1990;24:147–152
  6. Yang FY, Lin ZH, Li SG, et al. Keshan disease–an endemic mitochondrial cardiomyopathy in China. Journal of Trace Elements and Electrolytes in Health and Disease. 1988;2:157–163
  7. Dumont JE, Corvilain B, Contempre B. The biochemistry of endemic cretinism: roles of iodine and selenium deficiency and goitrogens. Molecular and Cellular Endocrinology. 1994;100:163–166
  8. Vanderpas J. Nutritional epidemiology and thyroid hormone metabolism. Annual Review of Nutrition. 2006;26(1):293–322
  9. Contempre B, Dumont JE, Ngo B, et al. Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. Journal of Clinical Endocrinology & Metabolism. 1991;73:213–215
  10. Contempre B, Duale NL, Dumont JE, et al. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clinical Endocrinology Oxford. 1992;36:579–583
  11. Vanderpas JB, Contempré B, Duale NL, et al. Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. The American Journal of Clinical Nutrition. 1993;57:271S–275S
  12. Contempre B, Le Moine O, Dumont JE, et al. Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor β (TGF-β). Molecular and Cellular Endocrinology. 1996;124:7–15
  13. Duntas LH. Environmental factors and autoimmune thyroiditis. Nature Clinical Practice Endocrinology & Metabolism. 2008;8:454–460
  14. Hoffmann PR, Berry MJ. The influence of selenium on immune responses. Molecular Nutrition & Food Research. 2008;52(11):1273–1280
  15. Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium's role in the immune system. Annals of the New York Academy of Sciences. 1990;587:123–139
  16. McKenzie RC, Rafferty TS, Beckett GJ. Selenium: an essential element for immune function. Immunology Today. 1998;19:342–345
  17. Flohé L, Aumann K-D, Steinert P. Role of selenium in the enzymatic reduction of hydroperoxides. Phosphorous Sulfur Silicon. 1998;136–138:25–42
  18. Bonomini M, Forster S, De-Risio F, et al. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis. Nephrology Dialysis Transplantation. 1995;10:1654–1661
  19. Vunta H, Davis F, Palempalli UD, et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. The Journal of Biological and Chemistry. 2007;282:17964–17973
  20. Vunta H, Belda BJ, Arner RJ, et al. Selenium attenuates pro-inflammatory gene expression in macrophages. Molecular Nutrition & Food Research. 2008;52(11):1316–1323
  21. Kikumori T, Kambe F, Nagaya T, et al. Activation of transcriptionally active nuclear factor-κB by tumor necrosis factor-α and its inhibition by antioxidants in rat thyroid FRTL-5 cells. Endocrinology. 1998;139:1715–1722
  22. Makropoulos V, Bruening T, Schulze-Osthoff K. Selenium-mediated inhibition of transcription factor NF-kappa-B and HIV-1LTR promoter activity. Archives Toxicology. 1996;70:277–283
  23. Gärtner R, Gasnier BCH. Selenium in the treatment of autoimmune thyroiditis. Biofactors. 2003;19:165–170
  24. Gärtner R, Gasnier BCH, Dietrich JW, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. The Journal of Clinical Endocrinology and Metabolism. 2002;87:1687–1691
  25. Duntas LH, Mantzou E, Koutras DA. Effects of a six-month treatment with selenomethionine in patients with autoimmune thyroiditis. European Journal of Endocrinology. 2003;148:389–393
  26. Karanikas G, Schuetz M, Wahl K, et al. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clinical Endocrinology Oxford. 2005;63:191–196
  27. Karanikas G, Schuetz M, Kontur S, et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid. 2007;18(1):7–12
  28. Mazokopakis EE, Papadakis JA, Maria G, et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid. 2007;17:609–612
  29. Moncayo R, Moncayo H, Kapelari K. Nutritional treatment of incipient thyroid autoimmune disease. Influence of selenium supplementation on thyroid function and morphology in children and young adults. Clinical Nutrition. 2005;24:530–531
  30. Schmidt KJ, Bayer W, Schweizer T, et al. Selensubstitution – ein therapeutischer Ansatz bei Schilddrüsenerkrankungen?. Vitaminspur. 1998;13:33–39
  31. Turker O, Kumanlioglu K, Karapolat I, et al. Selenium treatment in autoimmune thyroiditis: 9-months follow-up with variable doses. Journal of Endocrinology. 2006;190:151–156
  32. Peretz A, Néve J, Duchataeu JP, et al. Adjuvant treatment of recent onset rheumatoid arthritis by selenium supplementation. British Journal of Rheumatology. 1992;31:281–286
  33. Knekt P, Heliovaara M, Aho K, et al. Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. Epidemiology. 2000;11(4):402–405
  34. Angstwurm MWA, Schottdorf J, Schopohl J, et al. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Critical Care Medicine. 1999;27:1807–1813
  35. Angstwurm MW, Engelmann L, Zimmermann T, et al. Selenium in Intensive Care (SIC) study: results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock*. Critical Care Medicine. 2007;35:118–126
  36. Contempre B, Dumont JE, Denef JF, et al. Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. European Journal of Endocrinology. 1995;133:99–109
  37. Colzani RM, Alex S, Fang SL, et al. Effects of iodine repletion on thyroid morphology in iodine and/or selenium deficient rat term fetuses, pups and mothers. Biochimie. 1999;81:485–491
  38. Lehmann P, Rank P, Hallfeldt KL, et al. Dose-related influence of sodium selenite on apoptosis in human thyroid follicles in vitro induced by iodine, EGF, TGF-beta, and H2O2. Biological Trace Element Research. 2006;112:119–130
  39. Reid Mary E, Duffield-Lillico Anna J, Slate Elizabeth H, et al. The nutritional prevention of cancer: 400Mcg per day selenium treatment. Nutrition and Cancer. 2008;60(2):155–163
  40. Ericsson UB, Erfurth EM, Schutz A. Serum selenium concentrations in patients with autoimmune thyroiditis and non-toxic nodular goiter. Thyroidology. 1993;5:21–24
  41. Derumeaux H, Valeix P, Castetbon K, et al. Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. European Journal of Endocrinology. 2003;48(3):309–315
  42. Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nature Clinical Practice Endocrinology & Metabolism. 2008;47:394–405
  43. Negro R, Pezzarossa A, Dazzi D, et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. The Journal of Clinical Endocrinology and Metabolism. 2007;92:1263–1268
  44. Chanoine JP, Neve J, Wu S, et al. Selenium decreases thyroglobulin concentrations but does not affect the increased thyroxine-to-triiodothyronine ratio in children with congenital hypothyroidism. The Journal of Clinical Endocrinology and Metabolism. 2001;86(3):1160–1163
  45. Harbige LS. Nutrition and immunity with emphasis on infection and autoimmune disease. Nutrition and Health. 1996;10(4):285–312
  46. Sheridan PA, Zhong N, Carlson BA, et al. Decreased selenoprotein expression alters the immune response during influenza virus infection in mice. Journal of Nutrition. 2007;137(6):1466–1471
  47. Beck MA, Nelson HK, Shi Q, et al. Selenium deficiency increases the pathology of an influenza virus infection. The FASEB Journal. 2001;15:1481–1483
  48. Beck MA, Shi Q, Morris VC, et al. Rapid genomic evolution of a non-virulent Coxsackie B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Medicine. 1995;1:433–436
  49. Gärtner R. Selenium and thyroid hormone axis in critical ill states: an overview of conflicting view points. Journal of Trace Elements in Medicine and Biology. 2009;23(2):71–74
  50. Faure P, Ramon O, Favier A, et al. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. European Journal of Clinical Investigation. 2004;34:475–481
  51. Kretz-Remy C, Arrigo AP. Selenium: a key element that controls NF-kappa B activation and I kappa B alpha half life. Biofactors. 2001;14:117–125
  52. Hayashi T, Ueno Y, Okamoto T. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. The Journal of Biological and Chemistry. 1993;268:11380–11388
  53. Duntas LH. Selenium and inflammation: underlying anti-inflammatory mechanisms. Hormone and Metabolic Research. 2009;41(6):443–447
  54. Hasselmark L, Malmgren R, Zetterstrom O, et al. Selenium supplemention in intrinsic asthma. Allergy. 1993;48:30–36
  55. Curran JE, Jowett JB, Elliott KS, et al. Genetic variation in selenoprotein S influences inflammatory response. Nature Genetics. 2005 Nov;37(11):1234–1241
  56. Rayman MP. Selenoproteins and human health: insights from epidemiological data. Biochimica et Biophysica Acta (BBA) - general subjects uncorrected proof, (in press).
  57. Martinez A, Santiago JL, Varade J, et al. Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases. BMC Genomics. 2008;9:329
  58. Schweizer U, Chiu J, Köhrle J. Peroxides and enzymes in the thyroid. Antioxidants & Redox Signaling. 2008;10(9):1577–1592
  59. Behne D, Kyriakopoulos A, Meinhold H, et al. Identification of type I iodothyronine 5′-deiodinase as a selenoenzyme. Biochemmical and Biophysical Research Community. 1990;173:1143–1149
  60. Köhrle J. Thyroid carcinoma: interrelationships between local thyroid hormone metabolism by the type I 5′-deiodinase and the expression of thyroid hormone receptors and other thyroid-specific (de-)differentiation markers. Current Topics in Pathology. 1997;91:83–116
  61. Köhrle J. The trace element selenium and the thyroid gland. Biochimie. 1999;81(5):527–533
  62. Behne D, Kyriakopoulos A. Effects of dietary selenium on the tissue concentrations of type I iodothyronine 5′-deiodinase and other selenoproteins. American Journa of Clinical Nutrition. 1993;57:310S–312S
  63. Bermano G, Nicol F, Dyer JA, et al. Selenoprotein gene expression during selenium-repletion of selenium-deficient rats. Biological Trace Element Research. 1996;51:211–223
  64. Zagrodzki P, Nicol F, Arthur JR, et al. Selenoproteins in human thyroid tissues. Biofactors. 2001;14(1–4):223–227
  65. Streckfuss F, Hamann I, Schomburg L, et al. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice. Biochemmical and Biophysical Research Community. 2005;337(2):739–745
  66. Schomburg L, Riese C, Michaelis M, et al. Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice. Endocrinology. 2006;147(3):1306–1313
  67. Schweizer U, Weitzel JM, Schomburg L. Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Molecular and Cellular Endocrinology. 2008;289(1–2):1–9
  68. Shrimali RK, Irons RD, Carlson BA, et al. Selenoproteins mediate T cell immunity through an antioxidant mechanism. The Journal of Biological and Chemistry. 2008;283(29):20181–20185
  69. Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–241
  70. Reimund JM, Hirth C, Koehl C, et al. Antioxidant and immune status in active Crohn's disease. A possible relationship. Clinical Nutrition. 2000;19:43–48
  71. Köhrle J, Schomburg L. Selen - Selenoproteine - Selenmangel – Selenvergiftung. In:  Dunkelberg H,  Gebel T,  Hartwig A editor. Handbuch Lebensmitteltoxikologie. Weinheim, Germany: Wiley-VCH; 2008;p. 2403–2446
  72. Burk RF, Norsworthy BK, Hill KE, et al. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiological Biomarkers & Prevention. 2006;15(4):804–810
  73. Suzuki KT, Somekawa L, Kurasaki K, et al. Simultaneous tracing of (76)Se-selenite and (77)Se-selenomethionine by absolute labeling and speciation. Toxicology and Applied Pharmacology. 2006;217(1):43–50
  74. Nickel A, Kottra G, Schmidt G, et al. Characteristics of transport of selenoamino acids by epithelial amino acid transporters. Chemico-Biological Interactions. 2009;177(3):234–241
  75. Köhrle J, Brigelius-Flohé R, Böck A, et al. Selenium in biology: facts and medical perspectives. Biological Chemistry. 2000;381:849–864
  76. Schomburg L, Schweizer U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochimica et Biophysica Acta (in press).
  77. Rayman MP. Food-chain selenium and human health: emphasis on intake. British Journal of Nutrition. 2008;100(2):254–268
  78. Reid ME, Stratton MS, Lillico AJ, et al. A report of high-dose selenium supplementation: response and toxicities. Journal of Trace Elements in Medicine and Biology. 2004;18(1):69–74
  79. Hawkes WC, Laslett LJ. Selenium supplementation does not improve vascular responsiveness in healthy North American men. American Journal of Physiology. Heart and Circulatory Physiology. 2009;296(2):H256–H262
  80. Roy G, Mugesh G. Selenium analogues of antithyroid drugs–recent developments. Chemistry and Biodiversity. 2008;5(3):414–439
  81. Köhrle J. Iodothyronine deiodinases. Methods in Enzymology. 2002;347:125–167
  82. Köhrle J. Selenium and the control of thyroid hormone metabolism. Thyroid. 2005;15:841–853
  83. Bianco AC, Salvatore D, Gereben B, et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews. 2002;23:38–89
  84. Kim BW, Daniels GH, Harrison BJ, et al. Overexpression of Type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. Journal of Clinical Endocrinology & Metabolism. 2003;88(2):594–598
  85. Beckett GJ, Beech S, Nicol F, et al. Species differences in thyroidal iodothyronine deiodinase expression and the effect of selenium deficiency on its activity. Journal of Trace Elements and Electrolytes in Health and Disease. 1993;7:123–124
  86. Laurberg P. Iodothyronine secretion from perfused dog thyroid lobes after prolonged thyrotropin treatment in vivo. Endocrinology. 1981;109:1560–1565
  87. Chanoine JP, Braverman LE, Farwell AP, et al. The thyroid gland is a major source of circulating T3 in the rat. Journal of Clinical Investigation. 1993;91:2709–2713
  88. Maia AL, Kim BW, Huang SA, et al. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. Journal of Clinical Investigation. 2005;115:2524–2533
  89. Ambroziak M, Pachucki J, Chojnowski K, et al. Pax-8 expression correlates with type II 5′ deiodinase expression in thyroids from patients with Graves' disease. Thyroid. 2003;13:141–148
  90. Brtko J, Bobalova J, Podoba J, et al. Thyroid hormone receptors and type I iodothyronine 5′-deiodinase activity of human thyroid toxic adenomas and benign cold nodules. Experimental and Clinical Endocrinology. 2002;110(4):166–170
  91. Peeters RP, van der Deure WM, Visser TJ. Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. European Journal of Endocrinology. 2006;155:655–662
  92. Dumitrescu AM, Liao XH, Abdullah MS, et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nature Genetics. 2005;37:1247–1252
  93. Schomburg L, Dumitrescu AM, Liao XH, et al. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid. 2009;19(3):277–281

PII: S1521-690X(09)00081-5

doi: 10.1016/j.beem.2009.08.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 815-827 , December 2009

Article Tools

* Image Usage & Resolution